Clinical Trials in Texas

Showing 10221-10240 of 15,101 trials

PSA-Activated PSA-PAH1 for Locally Recurrent Prostate Cancer

NCT00379561

This Phase 1 trial will evaluate the safety and tolerability of PSA-Activated PSA-PAH1 in subjects who have shown biochemical failure and have either completed at least one primary radiation therapy for prostate cancer and have evidence of recurrent local prostate cancer without metastases.

Prostate Cancer

Sophiris Bio Corp24 participantsStarted Mar 2006

Temple, Texas, United States

COMPLETEDPhase 355 miles

Randomized, Double-blind, Placebo Controlled, Multi-center and Tolerability of RBP-7000 in Schizophrenia Patients

NCT02109562

The purpose of this study is to evaluate the efficacy and safety of RBP-7000 compared with placebo in the treatment of patients with schizophrenia. This will be a double-blind, placebo-controlled, Phase III study with 90 mg and 120 mg doses of RBP-7000 compared with placebo over an 8-week treatment period.

Schizophrenia

Indivior Inc.354 participantsStarted Apr 2014

Little Rock, Arkansas, United States • Springdale, Arkansas, United States • Cerritos, California, United States +29 more locations

PSA-Activated PSA-PAH1 for Locally Recurrent Prostate Cancer

Randomized, Double-blind, Placebo Controlled, Multi-center and Tolerability of RBP-7000 in Schizophrenia Patients

Find Trials by Condition in Texas

A Study in Subjects With Moderate Atopic Dermatitis

Pharmacokinetics of 122-0551 and Its Effects on Adrenal Suppression

A Study of LY2216684 in Major Depressive Disorder in Patients Taking Selective Serotonin Reuptake Inhibitors

Long-term Open-Label Safety Study to Evaluate EN3409

Vidaza to Restore Hormone Thx Prostate

BKM120 for Patients With PI3K-activated Tumors

Safety and Efficacy of OMS103HP-S Administered in Joint Irrigation Solution to Subjects Undergoing Arthroscopic Meniscectomy

Hepatic Impairment Study For Crizotinib In Advanced Cancer Patients

The Purpose of This Study is to Determine if Tetrodotoxin (TTX) is Effective in the Treatment of Pain Resulting From Chemotherapy Treatment

Bevacizumab and Erlotinib After Radiation Therapy and Temozolomide in Treating Patients With Newly Diagnosed Glioblastoma Multiforme or Gliosarcoma

Extension Study to Evaluate Long Term Safety of Denosumab in Subjects Undergoing ADT for Non-Metastatic Prostate Cancer

A Study of AT1001 (Migalastat Hydrochloride) in Participants With Fabry Disease

Safety and Tolerability Study of MEDI-551, a B-cell Depleting Agent, to Treat Relapsing Forms of Multiple Sclerosis

Safety and Efficacy of OMS643762 in Subjects With Huntington's Disease

Safety and Efficacy Study to Compare IV CXA 101/Tazobactam and Metronidazole With Meropenem in Complicated Intraabdominal Infections

Study Comparing the Safety and Efficacy of Intravenous CXA-201 and Intravenous Levofloxacin in Complicated Urinary Tract Infection, Including Pyelonephritis

PEDS-C: Pegylated Interferon +/- Ribavirin for Children With Hepatitis C

Pharmacodynamics and Pharmacokinetics Study of Existing DMPA Contraceptive Methods